| Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement (NCT02365415) | Boston Children's Hospital | 2015-02-01 |
| A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy (NCT02435862) | Allegro Ophthalmics, LLC | 2015-02-01 |
| Assessment of V0018 1.5 mg Effect on Craving (NCT02359201) | Pierre Fabre Medicament | 2015-02-01 |
| A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism (NCT02369796) | Takeda | 2015-02-01 |
| Sildenafil and Outcome of IVF/ICSI Cycles (NCT03192709) | Royan Institute | 2015-02-01 |
| A Study of Autologous Bone Marrow-Derived Mononuclear Stem Cells (BM-MNC) and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS (NCT02587806) | Novo Cellular Medicine Institute LLP | 2015-02-01 |
| Subcutaneous Sterile Water Injection for Relief of Low Back Pain (NCT02813330) | Woman's Health University Hospital, Egypt | 2015-02-01 |
| A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS (NCT02587715) | Novo Cellular Medicine Institute LLP | 2015-02-01 |
| Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? (NCT03014882) | Ain Shams University | 2015-02-01 |
| CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (NCT02365714) | Georgetown University | 2015-02-01 |
| ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma (NCT02431403) | Pusan National University Hospital | 2015-02-01 |
| Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers (NCT02296671) | Washington University School of Medicine | 2015-02-01 |
| Hyperbaric Oxygen Therapy for Lung Transplantation (NCT02363959) | Duke University | 2015-02-01 |
| A Study to Investigate the Differential Effects of Inhaled Symbicort and Advair on Lung Microbiota (NCT02833480) | University of British Columbia | 2015-02-01 |
| Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas (NCT02409576) | National University Hospital, Singapore | 2015-02-01 |
| Iloprost for Bridging to Heart Transplantation in PH (NCT02482402) | Heidelberg University | 2015-02-01 |
| Everolimus for Children With Recurrent or Progressive Ependymoma (NCT02155920) | University of Texas Southwestern Medical Center | 2015-02-01 |
| Omega-3 Supplementation and Behavior Problems (NCT02334098) | Dr. Annis Fung | 2015-02-01 |
| The Effect of Individualised Homoeopathic Treatment of Autism Spectrum Disorder in Children (NCT02363673) | University of Johannesburg | 2015-02-01 |
| ACTHAR GEL for Sarcoidosis-Associated Calcium Dysregulation: An Open-label Pilot Study (NCT02155803) | Albany Medical College | 2015-02-01 |
| MRX-I Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection (NCT02269319) | MicuRx | 2015-02-01 |
| Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy (NCT02501551) | Yonsei University | 2015-02-01 |
| Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) (NCT02349516) | Starr Muscle | 2015-02-01 |
| A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma (NCT02347917) | Sumitomo Pharma Co., Ltd. | 2015-02-01 |
| A Randomized Control Trial of Antibiotic Treatment Duration For Asymptomatic Bacteriuria After Kidney Transplantation (NCT02575495) | Mahidol University | 2015-02-01 |
| Photodynamic Therapy in Endodontic Treatment (NCT02824601) | Universidade Estadual Paulista Júlio de Mesquita Filho | 2015-02-01 |
| Hyperbaric VO2max Study (NCT02356900) | Duke University | 2015-02-01 |
| Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer (NCT02520063) | University of Alabama at Birmingham | 2015-02-01 |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (NCT02361346) | Molecular Templates, Inc. | 2015-02-01 |
| Effect of the Aquaretic Tolvaptan on Nitric Oxide System (NCT02527863) | Regional Hospital Holstebro | 2015-02-01 |
| A Study of BBI503 in Adult Patients With Advanced Hepatobiliary Cancer (NCT02232633) | Sumitomo Pharma America, Inc. | 2015-02-01 |
| Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839 (NCT02306811) | Genzyme, a Sanofi Company | 2015-02-01 |
| Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent (NCT02255864) | Amaranth Medical Inc. | 2015-02-01 |
| Antiplatelet Therapy in HIV (NCT02559414) | NYU Langone Health | 2015-02-01 |
| Role of the Nitric Oxide (NO) in Pre-oxygenation Before Anesthetic Induction in Patients With a Pulmonary Hypertension in Cardiac Surgery. Pilot Study of Feasibility (NCT02345616) | University Hospital, Clermont-Ferrand | 2015-02-01 |
| A Phase Ib Induced Malaria Infection Study With the Combination of OZ439 and DSM265 (NCT02389348) | Medicines for Malaria Venture | 2015-02-01 |
| A Study of OligoG in Cystic Fibrosis Subjects With Burkholderia Spp. Infection (NCT02453789) | AlgiPharma AS | 2015-02-01 |
| Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy (NCT02367014) | Stealth BioTherapeutics Inc. | 2015-02-01 |
| Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T (NCT02332902) | The University of Texas Health Science Center, Houston | 2015-02-01 |
| An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 Disease (NCT02485899) | BioMarin Pharmaceutical | 2015-02-01 |
| Study of Ibrutinib in Subjects With Acute Myeloid Leukemia (NCT02351037) | Pharmacyclics LLC. | 2015-02-01 |
| Traumatic Optic Neuropathy Treatment Trial (TONTT) (NCT01783847) | Tehran University of Medical Sciences | 2015-02-01 |
| Diclofenac Plus Lidocaine Gel for Pain Relief During Intrauterine Device Insertion(IUD). (NCT02332057) | Cairo University | 2015-02-01 |
| The Improving Effect of Autologous Stromal Vascular Fraction (SVF) in Adipose Tissue on Skin Grafting (NCT02546882) | Shanghai Jiao Tong University School of Medicine | 2015-02-01 |
| A Phase I/II Double-blind Safety and Efficacy Evaluation of Nowarta110 in Patients With Plantar Warts (NCT02338336) | Nowarta Biopharma Inc | 2015-02-01 |
| A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS (NCT02418325) | Genesis Limited | 2015-02-01 |
| Treatment of Refractory Chronic Cough With PA101 (NCT02412020) | Patara Pharma | 2015-02-01 |
| Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX (NCT02338505) | Catholic University of the Sacred Heart | 2015-02-01 |
| Assessment of V0018 2.5 mg Effect on Craving (NCT02357888) | Pierre Fabre Medicament | 2015-02-01 |
| Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR) (NCT02397928) | NovoCure Ltd. | 2015-02-01 |
| Role of Mesh Stoma Reinforcement Technique (MSRT) in Prevention of Parastomal Hernia After Ileal Conduit Urinary Diversion (NCT02387333) | Mansoura University | 2015-02-01 |
| Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome (NCT02544152) | Sucampo Pharma Americas, LLC | 2015-02-01 |
| Attention Bias Modification for Anxiety: A Randomized Control Trial With Biomarkers (NCT02200003) | Hunter College of City University of New York | 2015-02-01 |
| Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy (NCT02300727) | Amy Beres | 2015-02-01 |
| Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults (NCT02480998) | Il-Yang Pharm. Co., Ltd. | 2015-02-01 |
| Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. (NCT02571972) | Wills Eye | 2015-02-01 |
| Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants (NCT02367885) | Takeda | 2015-02-01 |
| Botox Injection in Treatment of Chronic Migraine (NCT02259075) | Norwegian University of Science and Technology | 2015-02-01 |
| The Lira Pump Trial (NCT02351232) | Hvidovre University Hospital | 2015-02-01 |
| This is a Randomized Study Comparing Two Doses of INT131 ( 3 mg and 1 mg) Administered Orally (PO) Daily (QD) Versus Placebo 1 Tablet PO QD in Subjects With Treatment-naïve RRMS for ≤ 3 Years (NCT02638038) | InteKrin Therapeutics, Inc. | 2015-02-01 |
| Planning Treatment for Oesophago-gastric Cancer: a Maintenance Therapy Trial (NCT02678182) | Royal Marsden NHS Foundation Trust | 2015-02-01 |
| Phase II Study of Cobimetinib in Combination With Vemurafenib in Active Melanoma Brain Metastases (NCT02230306) | Melissa Burgess, MD | 2015-02-01 |
| Trial of Vitamin C as Add on Therapy for Children With Idiopathic Epilepsy (NCT02369822) | Ain Shams University | 2015-02-01 |
| A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection (NCT02367313) | Biota Pharmaceuticals, Inc. | 2015-02-01 |
| Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea (NCT02342171) | Institute of Tropical Medicine, Belgium | 2015-02-01 |
| HER2-positive Breast Cancer With Brain Metastasis (GCC 1345) (NCT01924351) | University of Maryland, Baltimore | 2015-02-01 |
| A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC (NCT02387216) | Elevation Oncology | 2015-02-01 |
| Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes (NCT02372253) | University of Alabama at Birmingham | 2015-02-01 |
| 6-Month Phase I/II Open Label PRTX-100 in Previous Rheumatoid Arthritis Study Participants and Sera Collection (NCT02330445) | Protalex, Inc. | 2015-02-01 |
| Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas (NCT02310971) | Prima BioMed Ltd | 2015-02-01 |
| Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract (NCT02254421) | Gilead Sciences | 2015-01-31 |
| A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia (NCT02255435) | Biogen | 2015-01-31 |
| Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH) (NCT02312687) | Kyowa Kirin, Inc. | 2015-01-30 |
| Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer (NCT02127073) | Montefiore Medical Center | 2015-01-30 |
| A Pilot RCT of the PRISM Intervention for AYAs With Cancer (NCT02340884) | Seattle Children's Hospital | 2015-01-30 |
| Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02272790) | AstraZeneca | 2015-01-30 |
| Clinical Efficacy of Autologous Mesenchymal Bone Marrow Stem Cells in Active & Progressive Multiple Sclerosis (NCT02166021) | Dimitrios Karussis | 2015-01-29 |
| Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis (NCT02357420) | Allergan | 2015-01-29 |
| Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma (NCT02073097) | Case Comprehensive Cancer Center | 2015-01-28 |
| Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma (NCT01740557) | M.D. Anderson Cancer Center | 2015-01-28 |
| Study to Assess the Efficacy and Safety of Three Doses of PT001 in Japanese Subjects With Moderate to Severe COPD (NCT03256552) | Pearl Therapeutics, Inc. | 2015-01-28 |
| Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012) (NCT02332720) | Merck Sharp & Dohme LLC | 2015-01-28 |
| Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) (NCT02773225) | B. Höchsmann | 2015-01-27 |
| PRe-Operative Gefitinib in Resectable EGFR Mutation Positive Lung Cancer With Sector Sequencing for Biomarker Discovery (NCT02804776) | National Cancer Centre, Singapore | 2015-01-27 |
| Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma (NCT02314052) | Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2015-01-27 |
| A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants (NCT02337738) | Takeda | 2015-01-27 |
| Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer (NCT02300922) | Nantes University Hospital | 2015-01-27 |
| An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT02305563) | Bristol-Myers Squibb | 2015-01-27 |
| Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (NCT02347176) | MedImmune LLC | 2015-01-23 |
| Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission (NCT02140255) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-23 |
| Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract (NCT02254408) | Gilead Sciences | 2015-01-23 |
| Neoadjuvant Vemurafenib + Cobimetinib + Atezolizumab in Melanoma: NEO-VC (NCT02303951) | University Hospital Tuebingen | 2015-01-22 |
| Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas (NCT02333565) | Assistance Publique Hopitaux De Marseille | 2015-01-22 |
| Induction Cisplatin and Capecitabine Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NCT03427359) | The University of Hong Kong-Shenzhen Hospital | 2015-01-22 |
| Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Genotype (GT)1 and GT2 Infection (MK-3682-011) (NCT02332707) | Merck Sharp & Dohme LLC | 2015-01-22 |
| Cholinesterase Inhibitor Discontinuation (NCT02248636) | VA Office of Research and Development | 2015-01-22 |
| Phase I/II Trial to Investigate BI 836858 in Myelodysplastic Syndromes (NCT02240706) | Boehringer Ingelheim | 2015-01-22 |
| CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma (NCT02027935) | M.D. Anderson Cancer Center | 2015-01-22 |
| MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine With Transgenic MAGE-A3 Insertion in Incurable MAGE-A3-Expressing Solid Tumours (NCT02285816) | Canadian Cancer Trials Group | 2015-01-22 |
| B Cell Induction in Pediatric Lung Transplantation (NCT02266888) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-01-22 |